Cargando…

Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors

Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are  potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the...

Descripción completa

Detalles Bibliográficos
Autores principales: Leipoldt, Franziska, Santos-Aberturas, Javier, Stegmann, Dennis P., Wolf, Felix, Kulik, Andreas, Lacret, Rodney, Popadić, Désirée, Keinhörster, Daniela, Kirchner, Norbert, Bekiesch, Paulina, Gross, Harald, Truman, Andrew W., Kaysser, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719088/
https://www.ncbi.nlm.nih.gov/pubmed/29213087
http://dx.doi.org/10.1038/s41467-017-01975-6
_version_ 1783284432891805696
author Leipoldt, Franziska
Santos-Aberturas, Javier
Stegmann, Dennis P.
Wolf, Felix
Kulik, Andreas
Lacret, Rodney
Popadić, Désirée
Keinhörster, Daniela
Kirchner, Norbert
Bekiesch, Paulina
Gross, Harald
Truman, Andrew W.
Kaysser, Leonard
author_facet Leipoldt, Franziska
Santos-Aberturas, Javier
Stegmann, Dennis P.
Wolf, Felix
Kulik, Andreas
Lacret, Rodney
Popadić, Désirée
Keinhörster, Daniela
Kirchner, Norbert
Bekiesch, Paulina
Gross, Harald
Truman, Andrew W.
Kaysser, Leonard
author_sort Leipoldt, Franziska
collection PubMed
description Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are  potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new protease inhibitors by genome mining.
format Online
Article
Text
id pubmed-5719088
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57190882017-12-08 Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors Leipoldt, Franziska Santos-Aberturas, Javier Stegmann, Dennis P. Wolf, Felix Kulik, Andreas Lacret, Rodney Popadić, Désirée Keinhörster, Daniela Kirchner, Norbert Bekiesch, Paulina Gross, Harald Truman, Andrew W. Kaysser, Leonard Nat Commun Article Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin and matlystatins are  potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new protease inhibitors by genome mining. Nature Publishing Group UK 2017-12-06 /pmc/articles/PMC5719088/ /pubmed/29213087 http://dx.doi.org/10.1038/s41467-017-01975-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Leipoldt, Franziska
Santos-Aberturas, Javier
Stegmann, Dennis P.
Wolf, Felix
Kulik, Andreas
Lacret, Rodney
Popadić, Désirée
Keinhörster, Daniela
Kirchner, Norbert
Bekiesch, Paulina
Gross, Harald
Truman, Andrew W.
Kaysser, Leonard
Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title_full Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title_fullStr Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title_full_unstemmed Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title_short Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
title_sort warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719088/
https://www.ncbi.nlm.nih.gov/pubmed/29213087
http://dx.doi.org/10.1038/s41467-017-01975-6
work_keys_str_mv AT leipoldtfranziska warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT santosaberturasjavier warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT stegmanndennisp warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT wolffelix warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT kulikandreas warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT lacretrodney warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT popadicdesiree warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT keinhorsterdaniela warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT kirchnernorbert warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT bekieschpaulina warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT grossharald warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT trumanandreww warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors
AT kaysserleonard warheadbiosynthesisandtheoriginofstructuraldiversityinhydroxamatemetalloproteinaseinhibitors